These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Identification of a plasmid-mediated AmpC beta-lactamase from clinical isolates of Escherichia coli and Klebsiella pneumoniae].
    Author: Wang Y, Li ZH.
    Journal: Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):685-8. PubMed ID: 16255953.
    Abstract:
    OBJECTIVE: To investigate the susceptibility and genotype characteristics of Escherichia coli and Klebsiella pneumoniae producing plasmid-mediated AmpC beta lactamase. METHODS: A total of 110 strains of Escherichia coli and Klebsiella pneumoniae were collected from patients hospitalized in our respiratory ward during January 2002-May 2004. The isolates harboring AmpC beta-lactamase were detected by three-dimensional test, and isoelectric focusing analysis, electroporation, PCR and DNA sequencing were performed to determine the genotypes. RESULTS: AmpC enzyme was detected in 9.30% (4/43) of the Escherichia coli isolates and 4.48% (3/67) of the Klebsiella pneumoniae isolates. The susceptibility test showed 7 isolates tested were all resistant to cefoxitin, and part of these strains were resistant to the third-generation cephalosporins, beta-lactams/beta-lactamase inhibitors, aztreonam, amikacin and ciprofloxacin, but most of them were susceptible to cefepime and imipenem. Three strains of Klebsiella pneumoniae and 2 strains of Escherichia coli transferred cefoxitin-resistance to recipients by electroporation. Results of PCR and DNA sequencing defined them to be DHA-1 AmpC beta-lactamase. CONCLUSION: Escherichia coli and Klebsiella pneumoniae producing plasmid-mediated AmpC beta lactamase were isolated from clinical strains in this hospital, and its gene can be transferred horizontally.
    [Abstract] [Full Text] [Related] [New Search]